NSW Pharmaceutical Science Group

The NSW Pharmaceutical Science Group was established in 1959 to “promote the dissemination and exchange of scientific and technical knowledge, particularly related to the Pharmaceutical Sciences”.

The Group has pursued this objective by the regular organisation of seminars with a panel of expert presenters. The presentations address specific topics or themes as variously applying to production, quality assurance, laboratory, regulatory and R&D of therapeutic goods.


Upcoming Events

Click here to register. 

This webinar is free for members and students with a $10 charge made for non- RACI members.

Registrations close at COB, Monday 12 June.  Owing to webinar setup activities, later registration applications cannot be accepted.


Past Events

Expand to view available recordings and presentations

Expand AllCollapse All
  • Clinical Trials – Expertises, Resources, Collaborative Partnerships and Product Supply - Wednesday, 5 October 2022

    Clinical Trials in Australia

    Dr Duncan Macinnis, Director of Stakeholder Engagement (NSW/ACT), MTPConnect

    Clinical Trials in Drug Development

    Judy Bingham, Executive Director, Easington Pty Ltd

    GMP and other documentary requirements and guidelines for APIs and dose form

    David Edmonds, former Principal, CMC Regulatory

    Note – since this seminar TGA has updated its website and some links shown to the TGA website in this presentation may not be valid.

    From Bench to Clinic – Translating a new therapeutic into a commercially viable product for clinical trial

    Prof Paul Young, CEO, AB Initio Pharma


  • Manufacture and Quality Requirements of NMEs/APIs for Clinical Trials

    Dr Jurgen Lindner, Executive Secretary, APIMAA (Active Pharmaceutical Ingredient Manufacturers’

     Association of Australia)

    Specifications, Manufacture and Quality Requirements of Dose Form and Placebos for Clinical Trials

  • Craig Rogers, Director, Syntro Health


    The TGA presentation is not available to be posted on this website.

    A recording of this webinar, not including the TGA content, may be found here.

  • Establishing and Maintaining Data Integrity - Tuesday 25 October 2022
  • Presenters 1 : Dr Tony Manderson, Director, Scientific Operations Management Section, TGA 



Chair - Mr Scott Colbourne
Secretary - Mr Scott Colbourne
Treasurer - Mr David Edmonds
Committee Member - Mrs Niesha Davis
Committee Member - Ms Ivon Diaz
Committee Member - Ms Annette Fordham
Committee Member - Dr William Glover
Committee Member - Dr Chen Lim
Committee Member - Dr Jurgen Lindner
Committee Member - Mr Denis Moore
Committee Member - Mrs Noor Salman Qamar
Committee Member - Mr Gonzalo Verges
Committee Member - Dr Nial Wheate
Committee Member - Mrs Colleen Wood

Become Connected


If you would like get connected with NSW Pharm Group please contact us


  Contact us


Article: Regulatory and Other Requirements in Drug Development


David Edmonds, December 2019.


This article describes how, in conjunction with good and comprehensive science, a knowledge of TGA/Regulatory requirements and guidelines at the earliest stages of drug discovery and development should enhance the quality of the drug development.


The article can be downloaded here.